Flagship explainer

What drives RIGEL PHARMACEUTICALS, INC.’s return on equity?

ROE is five filed business factors multiplied together.

DuPont return on equity factor treeReturn on equity branches into tax burden, interest burden, operating margin, asset turnover, and the equity multiplier.Return on equity186%Tax burden301%net income ÷ pretax incomeInterest burden97%pretax ÷ operating incomeOperating margin43%operating income ÷ revenueAsset turnover0.87×revenue ÷ average assetsEquity multiplier1.72×average assets ÷ average equityAs of 2025-12-31 · 2 SEC filing sourcesBuy Like Buffett · buylikebuffett.com
DuPont source inputs
InputValueFiscal yearSource
$367MFY2025
Income before tax$122MFY2025
Operating income$125MFY2025
$294MFY2025
Ending assets$514MFY2025
Beginning assets$164MFY2024
$391MFY2025
$3.3MFY2024
Source: · event Dec 31, 2025 · retrieved Sep 4, 2026 · annual-row source set
Embed this chart

View the full RIGEL PHARMACEUTICALS, INC. analysis at Buy Like Buffett